A newly diagnosed patient with hypertension 37 year old female with BP 160/90 mmhg should i start with amlodipine 5 mg or telmisartan 40 mg
"hypertension" AND "first-line treatment" AND "young adults"
"hypertension" AND "amlodipine" AND "ARB" AND "guideline"
"hypertension"[MeSH Terms] AND "antihypertensive agents"[MeSH Terms]
PMID: 39210715
PMID: 40811516
"Suitable antihypertensive agents [in women] include labetalol, nifedipine, methyldopa, hydralazine, and prazosin... Diltiazem may..." - Comprehensive Clinical Nephrology, 7th Edition
| Guideline | First-Line Agents | Combination advice |
|---|---|---|
| 2025 AHA/ACC | Thiazide diuretics, CCBs, ACE inhibitors or ARBs | Two-drug combo if BP >20/10 above goal |
| 2024 ESC | ACEi or ARB + CCB or diuretic | Preferred dual combo = RAS + CCB |
| European Algorithm | ACEi/ARB + CCB (preferred) | See diagram below |

Step 1: Check pregnancy / contraceptive status
↓
Is she pregnant or planning pregnancy?
YES → Amlodipine 5 mg alone (NO ARBs)
NO (with reliable contraception) → Go to Step 2
↓
Step 2: BP 160/90 - above monotherapy threshold
Start DUAL therapy:
Amlodipine 5 mg + Telmisartan 40 mg (once daily)
[Or equivalent fixed-dose combination tablet]
↓
Step 3: Reassess in 4 weeks
Target BP < 130/80 mmHg (2025 AHA/ACC)
or < 140/90 mmHg (ESC for most adults)
| Feature | Amlodipine 5 mg | Telmisartan 40 mg |
|---|---|---|
| Pregnancy safety | Safe (CCB) | Contraindicated |
| BP lowering (monotherapy) | Comparable | Comparable |
| Side effects | Ankle edema (~10%) | Generally well tolerated |
| Special benefits | Antianginal, safe in all | Renoprotective (diabetes), cardioprotective post-MI |
| Once daily | Yes | Yes |
| Compelling indication in this patient? | None specified | None specified |
She is not pregnant
| Mechanism | Amlodipine (CCB) | Telmisartan (ARB) |
|---|---|---|
| How it lowers BP | Peripheral vasodilation via L-type Ca²⁺ channel blockade | Blocks AT1 receptor → reduces vasoconstriction + aldosterone |
| Compensatory reflex it triggers | Activates RAAS (reflex renin release) | Blocks RAAS |
| Net effect together | Each drug neutralizes the other's compensatory mechanism | Additive/synergistic BP reduction |
| Fluid retention | Mild tendency | Counteracts CCB-induced edema |
| Ankle edema | Reduced when ARB is added | - |
| Drug | Starting dose | Max dose |
|---|---|---|
| Amlodipine | 5 mg once daily | 10 mg once daily |
| Telmisartan | 40 mg once daily | 80 mg once daily |
For a 37-year-old non-pregnant female with BP 160/90 mmHg and no compelling comorbidities: Start Amlodipine 5 mg + Telmisartan 40 mg once daily as initial dual therapy. Do not delay with sequential monotherapy at this BP level. Target BP < 130/80 mmHg. Review at 4 weeks with electrolytes and renal function.